PreCheck Health Services, Inc. announced it has entered into a new exclusive distribution agreement with Co-Diagnostics Inc. This agreement gives the Company the exclusive distribution rights to Co-Diagnostics' qPCR infectious disease kits, Logix Smart COVID-19 PCR diagnostic test and Co-Dx Box instrument, in Afghanistan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan. This agreement follows the execution of agreements with Co-Diagnostics for Russia, Ecuador, Panama, Romania and Moldova. PreCheck's eleven combined distribution territories have an aggregate population of 298 million.

PreCheck believes Co-Diagnostics' Coronavirus COVID-19 PCR test is the most accurate test to detect the presence of the COVID-19 infection. Co-Diagnostics has announced that it was the first U.S. Company to obtain a CE marking for a COVID-19 test. CE marking is a certification mark that indicates conformity with health, safety, and environmental protection standards for products sold within the European Economic Area (the “EEA”).

The CE marking is also found on products sold outside the EEA that have been manufactured to EEA standards.